(18928389), M. C. J., (22676472), G. A. R., (6887384), J. M. S., (783181), N. C., (22676475), M. C. T., & (22676478), L. M. N. (2025). Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial: Aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
Lua i Stíl Chicago (17ú heag.)(18928389), Maria C. Jugan, Gabrielle A. Rands (22676472), Joerg M. Steiner (6887384), Natalia Cernicchiaro (783181), Matthew C. Tanner (22676475), agus Lillian M. Novotny (22676478). Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.
Lua MLA (9ú heag.)(18928389), Maria C. Jugan, et al. Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.